HTS Signs Proteomics Licensing Deal with Mitsubishi | GenomeWeb

NEW YORK, Feb 5 – Proteomics company HTS Biosystems of Hopkinton, Mass., said Monday that Mitsubishi Chemical of Japan has acquired the exclusive rights to distribute in Japan its bioanalysis system for protein detection.

Financial terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.